DK0480949T4 - Fremstilling af virusvaccine - Google Patents

Fremstilling af virusvaccine

Info

Publication number
DK0480949T4
DK0480949T4 DK90909595T DK90909595T DK0480949T4 DK 0480949 T4 DK0480949 T4 DK 0480949T4 DK 90909595 T DK90909595 T DK 90909595T DK 90909595 T DK90909595 T DK 90909595T DK 0480949 T4 DK0480949 T4 DK 0480949T4
Authority
DK
Denmark
Prior art keywords
virus
preparation
envelope glycoproteins
virus vaccine
isolating
Prior art date
Application number
DK90909595T
Other languages
English (en)
Other versions
DK0480949T3 (da
Inventor
Mary Elizabeth Ewasyshyn
Barry Ian Caplan
Anne-Marie Bonneau
Michel Henri Klein
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10659282&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0480949(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Publication of DK0480949T3 publication Critical patent/DK0480949T3/da
Application granted granted Critical
Publication of DK0480949T4 publication Critical patent/DK0480949T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK90909595T 1989-06-29 1990-06-28 Fremstilling af virusvaccine DK0480949T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898914968A GB8914968D0 (en) 1989-06-29 1989-06-29 Production of virus and purification of viral envelope proteins for vaccine use

Publications (2)

Publication Number Publication Date
DK0480949T3 DK0480949T3 (da) 1995-12-18
DK0480949T4 true DK0480949T4 (da) 2004-12-06

Family

ID=10659282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909595T DK0480949T4 (da) 1989-06-29 1990-06-28 Fremstilling af virusvaccine

Country Status (10)

Country Link
US (2) US6455050B1 (da)
EP (1) EP0480949B2 (da)
JP (1) JP2599503B2 (da)
AT (1) ATE130198T1 (da)
CA (1) CA2056437C (da)
DE (1) DE69023648T3 (da)
DK (1) DK0480949T4 (da)
ES (1) ES2078971T5 (da)
GB (1) GB8914968D0 (da)
WO (1) WO1991000104A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2142817C1 (ru) 1993-08-06 1999-12-20 Коннот Лабораториз Лимитед Инактивированные вакцины респираторно-синцитиального вируса
US7223410B1 (en) 1994-08-05 2007-05-29 Sanofi Pasteur Limited Inactivated respiratory syncytial viral vaccines
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
DK0784486T3 (da) * 1994-10-05 2006-08-14 Univ Vanderbilt Interleukin-12 som en adjuvans til Paramyxoviridae-vacciner
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
US6165774A (en) * 1995-09-22 2000-12-26 Connaught Laboratories Limited Parainfluenza virus glycoproteins and vaccines
US6020182A (en) * 1996-07-12 2000-02-01 Connaught Laboratories Limited Subunit respiratory syncytial virus vaccine preparation
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
DK1499348T3 (da) 2002-04-26 2015-01-05 Medimmune Llc Fremgangsmåde til fremstilling af infektiøse influenza b-vira i cellekultur
EP2481819A1 (en) 2003-02-25 2012-08-01 MedImmune Vaccines, Inc. Cross flow filtration in the production of stabilized influenza vaccine compositions
US20060110406A1 (en) 2003-02-25 2006-05-25 Medimmune Vaccines, Inc. Refrigerator-temperature stable influenza vaccine compositions
CA2551489C (en) 2003-12-23 2013-09-03 Gregory Duke Multi plasmid system for the production of influenza virus
EP2674486A1 (en) 2007-06-18 2013-12-18 MedImmune, LLC Influenza B viruses having alterations in the hemaglutinin polypeptide
US11446374B2 (en) 2008-12-09 2022-09-20 Novavax, Inc. Modified RSV F proteins and methods of their use
PL2370099T3 (pl) 2008-12-09 2016-10-31 Zmodyfikowane białka F RSV i sposoby ich zastosowania
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
CA2996007A1 (en) 2015-09-03 2017-03-09 Novavax, Inc. Vaccine compositions having improved stability and immunogenicity
JP7317796B2 (ja) 2017-07-24 2023-07-31 ノババックス，インコーポレイテッド 呼吸器疾患を治療するための方法および組成物
USD1096318S1 (en) * 2023-11-29 2025-10-07 Miir Holdings, Llc Cup

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699785A (en) * 1984-09-18 1987-10-13 The Regents Of The University Of California Cell line producing feline leukemia virus
MX9203458A (es) * 1987-12-23 1992-09-01 Upjohn Co Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano.
ATE105334T1 (de) * 1988-04-22 1994-05-15 Upjohn Co Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.

Also Published As

Publication number Publication date
DE69023648T3 (de) 2005-02-03
EP0480949A1 (en) 1992-04-22
US6455050B1 (en) 2002-09-24
JPH04502410A (ja) 1992-05-07
WO1991000104A1 (en) 1991-01-10
EP0480949B1 (en) 1995-11-15
CA2056437C (en) 1996-02-06
ES2078971T3 (es) 1996-01-01
JP2599503B2 (ja) 1997-04-09
DE69023648D1 (de) 1995-12-21
ES2078971T5 (es) 2005-03-16
CA2056437A1 (en) 1990-12-30
DE69023648T2 (de) 1996-05-02
DK0480949T3 (da) 1995-12-18
ATE130198T1 (de) 1995-12-15
EP0480949B2 (en) 2004-08-04
GB8914968D0 (en) 1989-08-23
US6306637B1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
DK0480949T4 (da) Fremstilling af virusvaccine
NZ237666A (en) Hiv envelope (env) polypeptides, antibodies and compositions for treating aids
DE69635907D1 (de) Neuartige nicht pyrogene bakterienstämme und ihre verwendung
NO304381B1 (no) FremgangsmÕte for fremstilling av hepatitt C-virus (HCV) og anvendelse derav i en immunoanalysemetode
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
BR8701528A (pt) Proteina,sequencia de dna,vetor recombinante,organismo celular,processos para producao de uma proteina e para a preparacao de um organismo unicelular,processos para a deteccao da presenca de anticorpos e de virus de aids,processos para a preparacao de uma vacina e para a preparacao de anticorpos,formulacao de vacina,anticorpos,uso,vacina,kit de teste e metodo para a prevencao de aids
DK1007061T3 (da) Fremgangsmåde til fremstilling af blodpladevækstfaktorekstrakt til sårhelingspræparater
NO893149D0 (no) Fremgangsmaate til mikrobiologisk fremstilling av humant serumalbumin og andre heterologe proteiner fra gjaer.
DE69535018D1 (de) Papillomavirus vakzine
ES2075440T3 (es) Vacuna contra la hepatitis b.
IT8621106A1 (it) Vettore ad espressione e secrezione in lieviti, utile per la preparazione di proteine eterologhe
ATE171471T1 (de) Isolierte virale proteine als cytokinantagonisten
DE60037450D1 (de) Funf-helix protein
EA200000528A1 (ru) Способ получения вакцин для предупреждения патогенных эффектов, связанных с ретровирусной инфекцией
DE69232906T2 (de) Detektion des Hepatis-C Virus.
WO1991015512A3 (en) Hiv envelope polypeptides
AU2567888A (en) Hiv peptides and methods for detection of hiv
IT1254360B (it) Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
FI924746A7 (fi) Kohydrolyysimenetelmä uusien uutteiden valmistamiseksi hiiva- ja ei-hi ivaproteiineista
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
OA09653A (en) Rubella peptides
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
RU93043621A (ru) Способы получения гликопротеинов нсv, способ очистки, аналитический набор, способ выявления нсv, способ элиминации нсv, способ индукции иммунитета, гликопротеины, иммунореагенты